Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Human Adenovirus B55 Infection in Patient without Recent Travel History, France
Menel Mohamedi
1, Marion Dutkiewicz
1, Clara Richard de Vesvrotte, Linda Feghoul, Abdeljalil Senhaji Rachik, Séverine Mercier-Delarue, Baptiste Hervier, Jérôme LeGoff, and Maud Salmona
Author affiliation: Virology Department, AP-HP, Hôpital Saint-Louis, Paris, France (M. Mohamedi, M. Dutkiewicz, L. Feghoul, A.S. Rachik, S. Mercier-Delarue, J. LeGoff, M. Salmona); Department of Internal Medicine, AP-HP, Hôpital Saint-Louis, Paris (C.R. de Vesvrotte, B. Hervier); Inserm UMR-S 976, INSIGHT Team, University Paris Cité, Paris (L. Feghoul, J. LeGoff, M. Salmona); Inserm UMR-S 976, HIPI, Université Paris Cité, Paris (B. Hervier)
Main Article
Figure 1
Figure 1. Timeline of medical care after patient’s admission to emergency department in study of HAdV-B55 infection in patient without recent travel history, France. NPS samples were negative for SARS-CoV-2, influenza, and RSV on D1, and urinary antigen tests for Legionella pneumophila and Streptococcus pneumoniae were also negative. HAdV-B55 was confirmed by whole-genome sequencing on D3 stool samples. D, day postadmission; HAdV-B55, human adenovirus B55; NPS, nasopharyngeal swab; RSV, respiratory syncytial virus; –, negative; +, positive.
Main Article
Page created: February 07, 2025
Page updated: March 12, 2025
Page reviewed: March 12, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.